share_log

Morgan Stanley Maintains Overweight on IDEXX Laboratories, Raises Price Target to $600

Benzinga ·  Aug 3, 2023 10:48

Morgan Stanley analyst Erin Wright maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and raises the price target from $590 to $600.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment